Jiang Rui, Zhang Chao, Liu Guangyao, Gu Rui, Wu Han
Department of Orthopedics, China-Japan Union Hospital of Jilin University, Changchun, China.
Department of Ophthalmology, The Second Hospital of Jilin University, Changchun, China.
J Cell Biochem. 2017 Nov;118(11):3765-3774. doi: 10.1002/jcb.26024. Epub 2017 May 18.
Osteosarcoma (OS) is a tumor with rapid progression, high metastatic potential and poor clinical prognosis. This study was aimed to investigate the function of miR-126 in OS cells. The miR-126 expression in OS cell lines and OS tissues were explored by qRT-PCR. Then, the effects of miR-126 on proliferation, cycle, migration, invasion, and transforming growth factor (TGF)-β1 induced epithelial to mesenchymal transition (EMT) were assessed. Predicted by TargetScan, one of target genes for miR-126 was verified by luciferase activity assay. Meantime, the mRNA and protein expressions of ZEB1 were assessed by qRT-PCR and Western blot assay. Subsequently, the effect of ZEB1 silence on miR-126 down-regulated cells was also evaluated. Finally, the expressions of key kinases involved in c-Jun N-terminal kinase (JNK) and Janus-activated kinase (JAK)-1/signal transducer and activator of transcription (STAT)-3 pathways were detected by Western blot analysis. Result showed that miR-126 was down-regulated in OS tissues and cell lines. Overexpression of miR-126 significantly inhibited cell proliferation, migration, invasion, and TGF-β1 induced EMT. The effect of miR-126 knockdown was just the opposite. ZEB1 was predicted and verified as a target gene of miR-126. Meantime, the influence of miR-126 knockdown was abrogated by ZEB1 silence. Additionally, the phosphorylation levels of c-Jun, JNK, JAK1, and STAT3 were down-regulated in miR-126 over-expressed cells, and the effect of miR-126 knockdown was reversed by ZEB1 silence. In conclusion, miR-126 inhibits proliferation, migration, invasion and EMT in OS by targeting ZEB1 through inactivation of JNK and JAK1/STAT3 pathways. J. Cell. Biochem. 118: 3765-3774, 2017. © 2017 Wiley Periodicals, Inc.
骨肉瘤(OS)是一种进展迅速、具有高转移潜能且临床预后较差的肿瘤。本研究旨在探究miR-126在骨肉瘤细胞中的功能。通过qRT-PCR检测骨肉瘤细胞系和骨肉瘤组织中miR-126的表达。然后,评估miR-126对细胞增殖、周期、迁移、侵袭以及转化生长因子(TGF)-β1诱导的上皮-间质转化(EMT)的影响。通过TargetScan预测,miR-126的一个靶基因经荧光素酶活性测定得到验证。同时,通过qRT-PCR和蛋白质免疫印迹法评估ZEB1的mRNA和蛋白质表达。随后,还评估了ZEB1沉默对miR-126下调细胞的影响。最后,通过蛋白质免疫印迹分析检测参与c-Jun氨基末端激酶(JNK)和Janus激活激酶(JAK)-1/信号转导及转录激活因子(STAT)-3通路的关键激酶的表达。结果显示,miR-126在骨肉瘤组织和细胞系中表达下调。miR-126过表达显著抑制细胞增殖、迁移、侵袭以及TGF-β1诱导的EMT。miR-126敲低的效果则相反。ZEB1被预测并验证为miR-126的靶基因。同时,ZEB1沉默消除了miR-126敲低的影响。此外,在miR-126过表达的细胞中,c-Jun、JNK、JAK1和STAT3的磷酸化水平下调,并且ZEB1沉默逆转了miR-126敲低的作用。总之,miR-126通过靶向ZEB1并使JNK和JAK1/STAT3通路失活,从而抑制骨肉瘤细胞的增殖、迁移、侵袭和EMT。《细胞生物化学杂志》118: 3765 - 3774, 2017。© 2017威利期刊公司